InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
32,000
-1,500 (-4.48%)
At close: Feb 27, 2026
31.15%
Market Cap 390.15B
Revenue (ttm) 226.62B
Net Income (ttm) 32.83B
Shares Out 12.19M
EPS (ttm) 2,626.56
PE Ratio 12.18
Forward PE 10.82
Dividend 400.00 (1.25%)
Ex-Dividend Date Mar 30, 2026
Volume 67,050
Average Volume 41,606
Open 33,150
Previous Close 33,500
Day's Range 31,450 - 33,450
52-Week Range 21,400 - 36,000
Beta 0.40
RSI 43.36
Earnings Date Feb 20, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.

Financial Statements

News

There is no news available yet.